Export promotion is a major strategy of TPICO which has two approaches of the expansion of present markets and creation of new markets taking heed of quality and competitive prices as well as offering new products to promote exports. To that end, the company’s exports have seen a hike and has managed to export its products specially potassium clavaulnate mixed with syloid and avicel and amoxicilin, lidocaine base and lidocaine HCL, nalidixic acid, piroxicam, atenolol, and ferrous fumarate to Germany, Russia, Ukrain, Turkey, Pakistan, Syria, Uzbakistan, the UAE, Bangladesh, Kazakhstan, Guatemala, Egypt, Singapore and Iraq. The company has registered its potassium clavulanate mixed with avicel and potassium clavulanate mixed with syloid in India. Setting this as target market, the company has put on its agenda the export of those products to the Indian sub-continent and its neighboring countries. The company plans to obtai COS to be able to export potassium clavulanate to European markets.